25th Annual Meeting of the Society of Urologic Oncology - TCAF Meet & Greet Social
On December 5, Testicular Cancer Awareness Foundation (TCAF) hosted a Meet & Greet Social sponsored by Fennec Pharmaceuticals during the 25th annual meeting of the Society of Urologic Oncology (SUO) in Dallas, Texas. 56 people attended this private gathering, including some of the top testicular cancer surgeons in North America.
TCAF’s Meet & Greet Socials are a great opportunity for experts in the testicular cancer field to connect, exchange ideas, and collaborate on advancements in care and research. Bringing together these professionals in a more informal setting can foster meaningful relationships that lead to impactful breakthroughs in the treatment and understanding of testicular cancer; it will help shape the future of care and treatments for their patients.
This was also a great opportunity to congratulate Clint Cary, MD, MPH, MBA on his newly appointed position as Chair of Urology at IU.
For TCAF, hosting events like this provides an opportunity to share our resources and programs that we provide to patients and their families. Together, we are making a positive, impactful difference in the fight against testicular cancer.
Special thanks to Fennec Pharmaceuticals for sponsoring this great event as well as their continued support in advancing our mission and most recently being the presenting sponsor of the 2024 Testicular Cancer Conference.
Fennec offers the first and only FDA approved hearing loss prevention for adolescents and young adults (AYA) who receive cisplatin chemotherapy to help reduce ototoxicity (hearing loss). Fennec’s hearing loss drug, Pedmark, is also recommended by the NCCN guidelines for patients 15-39 years of age. If you are about to start treatment for testicular cancer that includes cisplatin chemotherapy, contact Fennec HEARS at 1-833-7PEDMARK or 1-(833)-773-3627.
TCAF looks forward to attending more oncology and urology events and continuing to bring the community together. Stay tuned for more opportunities to engage with us in the fight against testicular cancer!